4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-011840
Options or other derivatives
- Chief Executive Officer acquired 168,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2022-02-18 | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2022-02-18 | Grant or award · Restricted Stock Units | +53,000 | 53,000 | D | ||
Loading xslF345X03/doc4.xml…